98%
921
2 minutes
20
Background: The chin significantly influences facial aesthetics, contributing to the overall balance and harmony of the face. This study aimed to assess the effectiveness of the hyaluronic acid filler Hyamax® Volumizer for chin augmentation and correction of chin retrusion compared to a no-treatment control.
Methods: Participants aged 18-55 years with mild to moderate chin retrusion were randomized in a 3:1 ratio to receive either the treatment group (n = 150) or control group (n = 50). Evaluations included blinded assessments using the validated Galderma Chin Retrusion Scale, Global Aesthetic Improvement Scale for aesthetic enhancement, and safety follow-up.
Results: The Galderma Chin Retrusion Scale responder rate (≥1 grade improvement) was significantly higher for the treatment group (70%) compared to the control group (0%) at 6 months (p < 0.0001), and remained higher at 12 months (54.67% vs. 0%; p < 0.0001). Aesthetic improvement rates were consistently high as reported by both blinded evaluating investigator (≥89.33%) and subjects (≥91.33%). Treatment-related adverse events were mild to moderate.
Conclusion: Hyamax® Volumizer treatment is safe and effective when injected in the chin to treat chin retrusion, with results lasting through 1 year.
Level Of Evidence I: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00266-024-04494-0 | DOI Listing |
JPRAS Open
September 2025
Clinic Aesthetics, 10 Harley Street, Marylebone, London, W1G 9PF, United Kingdom.
Objective: To investigate the effectiveness, safety, and versatility of injections with the same hyaluronic acid (HA) filler type in patients with signs of aging in the cheeks, chin, and/or jawline.
Methods: In this single-arm, prospective case series study, patients aged ≥18 years with reduced midface volume, chin retrusion, and/or loss of jawline contour were administered HA filler (Y-Solution® 720 [20 mg/mL]) and followed through 12 months. Main outcomes included midface volume (Midface Volume Loss Rating Scale [MFVLRS]), chin retrusion (Chin Retrusion Rating Scale [CRRS]), loss of jawline contour (Jawline Contour Rating Scale [JCRS]), satisfaction (FACE-Q™ [1, worst; 4, best]), and safety.
J Craniomaxillofac Surg
August 2025
Plastic Surgery Hospital and Institute, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China. Electronic address:
Purpose: Craniofacial microsomia (CFM), the second most common congenital craniofacial anomaly, is poorly characterized in bilateral cases because conventional cephalometry cannot accurately assess facial asymmetry. This study aims to characterize craniofacial morphology in children with bilateral CFM using three-dimensional (3D) cephalometric analysis.
Materials And Methods: A retrospective 3D cephalometric analysis was conducted on 8 bilateral CFM patients and 10 age-/sex-matched normal patients as controls.
J Imaging Inform Med
August 2025
Department of Orthodontics, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Orthognathic surgery is often required to address moderate to severe skeletal class II malocclusion, a condition that affects both facial aesthetics and function. Traditional diagnosis relies on cephalometric radiographs and expert evaluation, which can be time-consuming and subject to inter-observer variability. The need for AI-assisted initial screening based exclusively on lateral soft tissue profiles is increasingly recognized, particularly for identifying mandibular retrusion relative to the maxilla.
View Article and Find Full Text PDFAesthetic Plast Surg
July 2025
Allergan Aesthetics, Irvine, CA, USA.
Indian J Dent Res
June 2025
Department of Orthodontics and Dentofacial Orthopedics, Sri Ramachandra Dental College and Hospital, SRIHER (DU), Chennai, Tamil Nadu, India.
Skeletal Class III malocclusion in adolescents can be effectively managed using the combination of maxillary skeletal expander (MSE) and facemask (FM). An adolescent presented concerns about her lower front teeth positioned ahead of the upper front teeth, difficulty closing the lips, and dissatisfaction with the facial appearance. The patient exhibited a skeletal Class III profile, reverse overjet, a 2 mm overbite, concave facial profile, midface retrusion, mandibular prognathism, chin deviation to the right, and increased lower facial height (LFH).
View Article and Find Full Text PDF